This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Nasal Drug Development, Trends and Challenges with Nasal Formulations
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Nose to Brain Drug Delivery – A Promising Future
Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
Aptar Pharma Q&A on trends and challenges in nasal drug delivery
Publications, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation
Why it is time to think differently about Nasal delivery of Biologics
Publications, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions
